13.52 USD
▲+0.54+2.42%
盘后 13.10 -0.76%
2026-08-03
市值
$1.42B
市盈率
—
EPS
-1.02
股息率
—
52 周区间
3.84 – 16.39
成交量
1.68M
Beta
2.28
目标价
13.88
52W 低 3.8452W 高 16.39
价格走势
公司简介
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample....